3,3'-diaminobenzidine has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mitarnun, W; Nittayananta, W; Sriplung, H; Talungchit, S | 1 |
1 other study(ies) available for 3,3'-diaminobenzidine and HIV Coinfection
Article | Year |
---|---|
Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART.
Topics: 3,3'-Diaminobenzidine; Adult; Alcohol Drinking; Antiretroviral Therapy, Highly Active; Biopsy, Needle; CD4 Lymphocyte Count; Chromogenic Compounds; Cross-Sectional Studies; Epithelial Cells; Female; HIV; HIV Infections; HIV Seropositivity; Humans; Keratin-1; Keratin-13; Keratin-14; Keratin-16; Keratins; Male; Middle Aged; Mouth Mucosa; Protein Precursors; Smoking; Viral Load; Young Adult | 2012 |